For research use only. The compound discussed here is described purely as a subject of laboratory characterization. Most peptides researchers study are a single molecule with one defined sequence — you could sketch the structure on a napkin. Cerebrolysin is the opposite. It's a complex mixture, made by breaking down brain-tissue protein into hundreds of fragments, so the first chemistry question isn't "how does it work" but "what is actually in the vial?" This article traces where the material comes from, the two fractions it contains, why molecular size governs nearly everything about it, and how analysts pin down the contents of any given batch.
One housekeeping note before the chemistry. "Cerebrolysin" is also a registered pharmaceutical brand name in a number of countries. Research-grade material referred to by the same chemical description is not equivalent to, and should not be confused with, any approved pharmaceutical product. Everything below concerns the composition and analytical characterization of the substance, not its use.
What's Actually in the Vial
The short answer: two ingredient classes — free amino acids and small peptides — suspended in an aqueous solution. Cerebrolysin is a peptide-rich preparation of low-molecular-weight neuropeptides (under about 10 kDa) and free amino acids, produced by enzymatic breakdown of purified porcine (pig) brain protein. Nothing here is synthesized one molecule at a time; it's extracted and processed from biological tissue.
Published specifications put numbers on that blend. Per the documented composition, 1 mL of solution contains 215.2 mg of a low-molecular-weight fraction of polypeptides extracted from porcine brain — the "Cerebrolysin concentrate" — corresponding to at least 5.8 mg of peptide nitrogen. Proportionally, that's most often described as roughly 15% peptides and 85% free amino acids. Other sources put the ratio closer to 25% peptides and 75% amino acids, and that disagreement is itself instructive: with a mixture, the number you get depends on how you define and measure each fraction, not on a fixed molecular formula.
Made by hydrolysis, not by synthesis
The manufacturing route explains the contents. The material is made by a standardized enzymatic breakdown of lipid-free brain protein powder. Picture running a long document through a shredder set to leave legible fragments rather than confetti: you start with large intact proteins and end with a population of short pieces plus loose single residues. Lipids are stripped out first; enzymes then cleave the remaining proteins into peptides and amino acids. That's why "peptide-rich preparation" is the accurate label — and why calling Cerebrolysin "a peptide," singular, is a category error.
A Mixture, Not a Molecule
Here's what that distinction changes in practice: you can't reason about Cerebrolysin the way you'd reason about a defined compound. Take a single defined peptide like BPC-157, one exact 15-residue chain, or a peptide defined by one exact sequence such as DSIP. For those, structure is identity — name the residues in order and you've fully specified the molecule. You can model it, synthesize it to spec, and verify it against a single expected mass.